Sign In
to Vote &
Create Storyboards.
 

Now Comes the Hard Part at Teva

Wall Street Journal - 11 Sep 2017 22:18
Investors love Teva's new CEO, but falling generic drug prices and high debt will weigh on shares.
0
0
0


Storyboard
Print
Share this Article

Recommended

  • {TITLE}
    {PUBLISHER} - {PUBLISHED_DATE}
    {VIEWS}
  • Create Storyboard